November 14, 2014
Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated lung cancer information throughout the year.
The American Cancer Society (ACS) estimates that in 2013 there will be 228,190 new cases of lung cancer and estimated 159,480 deaths from lung cancer.[1] While there are more than a dozen different kinds of lung cancer, the two main types of lung cancer are non small cell and small cell, which together account for more than 90% of all lung cancers. Understanding treatment options, the role of different doctors specializing in the treatment of lung cancer, and how and when to access new and innovative cancer treatment options available through clinical trials is essential in order to achieve the best outcome from cancer treatment.
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?
- Sign up for monthly newsletters on lung cancer here.
- Get the facts about lung cancer here.
- Join ongoing discussions with other individuals affected by lung cancer in the CancerConnect private online lung cancer community here.
Ask the Expert Series: CancerConnect partnered with Dana-Farber Cancer Institute to provide you with the opportunity to engage with a lung cancer expert, David M. Jackman, MD, who answered questions and relayed important information about lung cancer. Dr. Jackman is a thoracic oncologist in the Lowe Center for Thoracic Oncology at Dana-Farber. Dr. Jackman focuses on lung cancer and mesothelioma. His clinical research interests include evaluating how to predict responses to targeted therapy in non-small cell lung cancer (NSCLC). Click here for Dr. Jackman’s bio.
Dr. Jackman’s answers to your questions are available here in the lung cancer community. Dr. Jackman discussed many lung cancer topics including the following:
- Questions about Immunotherapy
- Question about treatment with navelbine
- Screening for lung cancer
- Investigative drugs for Stage IV NSCLC
- Question about EGFR testing
- CO-1686 for EGFR mutation patients
- Treatment and infection
- Suspicious lung nodule
- Question about Progression
- Question about Avastin
- Immunotherapy and other clinical trials
- Treatment of SCLC
- Question about treatment for limited stage SCLC
- Question about Staging
- Question about debulking in advanced disease
- Bone Scans
- Follow up scans
Contact:
Charles H. Weaver, MD
chweaver@omnihealthmedia.com
Reference:
[1] American Cancer Society. Cancer Facts and Figures 2013. Available at http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. (Accessed November 14, 2013).